” section on KBank’s website. 9 Risk Management Structure Board of Directors Audit Committee Risk Management Committee Risk Management and Control Units Credit Risk Management Sub-committee Credit Process
UNOFFICIAL TRANSLATION Readers should be aware that only the original Thai text has legal force and that this English translation is strictly for reference. Notification of the Office of the Securities and Exchange Commission No. Sor Nor. 87/2558 Re: Rules, Conditions, and Procedures for Management of Retail Funds, Mutual Funds for Accredited Investors, Mutual Funds for Institutional Funds, and Private Funds ______________________ By virtue of Clause 6, Clause 8, and Clause 9 of the Notification...
, accurate and complete. 7) Opinions of the Audit Committee and / or directors that are different from the opinions of the Board of Directors On February 2 5 , 2 0 2 0 , the Audit Committee meeting considered
Audit Committee and/or Directors of the Company that different from the Board of Directors opinion; The Company convened Audit Committee’s Meeting No.1/2020 on 25 February 2020 in order to consider such
Transaction is appropriate and will be beneficial to the Company for the reasons mentioned in Item 8. 11. Opinion of the Audit Committee and/or Directors of the Company, which Differ from the Opinion of the
Company’s revenue in the future. 11. Opinion of the Audit Committee and/or Directors of the Company, which Differ from the Opinion of the Board of Directors as per Clause 10 The Audit Committee did not have
amount of 181.75 million shares, which represent 10.01% of issued and paid-up shares of TSE. 13. Opinion of the Audit Committee and/or the director(s) of the Company which is different from the Board of
Soi 54 Rd., Samae-Dam, Bang Khun Thian, Bangkok 10150 Tel. 02-897-8888, 02-897-8800 Fax. 02-897-8890 8. Opinions of the Audit Committee and/or the Directors of the Company having differing opinions from
comfortably. 8. Opinions of the Audit Committee and/or the Directors of the Company having differing opinions from the Board of Directors of the Company. The Audit Committee has the opinion in correspondence
Myco Biotech company limited is the first manufacturer to produce this potential product for expanding the revenue to the company in the future. 10. Opinion of the Audit Committee and/or the Directors